Darmiyan Inc. (www.darmiyan.com) is a San Francisco based braintech company innovating at the cross-section of neuroimaging, clinical big data, ML/ AI, and neurodegenerative disorders. Founded in 2016 by a team of acclaimed neuroscientists, clinicians, and AI experts, Darmiyan’s vision is to leverage technology to make a global impact on the lives of all people, especially those dealing with mild cognitive impairment, Alzheimer’s disease, and dementia.

Darmiyan’s mission is to help postpone & prevent dementia through:

– Early detection & early intervention  

– Monitoring patient-specific response to interventions

– Using data to advance drug development for Alzheimer’s disease